Lung Injury from Military Deployment Request More Information Trial Objective The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001. The information collected with be used to learn about respiratory diseases associated with the inhalation of very small particulate matter and other harmful substances during deployment. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Patients who have been seen at National Jewish Health for evaluation of respiratory symptoms and have been deployed during Operation Iraqi Freedom, Operation Enduring Freedom, Operation New Dawn or Operation Freedom’s Sentinel. Age: 18-70 Gender: Any Gender Estimated Time Commitment 1 to 2 visits × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Kathy Pang 303.398.1418 Michelle Kramaric 303.270.2634 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Department of Defense Principal Investigators Gregory Downey, MD + × Gregory Downey, MD Professor Executive Vice President, Academic Affairs Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 5 out of 5 stars Make an Appoinment Co-Investigators Brian Day, PhD + × Brian Day, PhD Professor Vice President of Research Director, Office of Research Innovation Department of Medicine View Full Profile Make an Appoinment Cecile Rose, MD, MPH + × Cecile Rose, MD, MPH Professor Department of Medicine Division of Environmental & Occupational Health Sciences View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Hong Wei Chu, MD + × Hong Wei Chu, MD Professor Assistant Vice President for Academic Affairs Research Director for the Office of Research Innovation View Full Profile Make an Appoinment Max Seibold, PhD + × Max Seibold, PhD Wohlberg and Lambert Endowed Chair of Pharmacogenomics Professor, Department of Pediatrics Director, Regenerative Medicine and Genome Editing Program (REGEN) Director, Computational Biology Program Center for Genes, Environment & Health University of Colorado-AMC, School of Medicine View Full Profile Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001. The information collected with be used to learn about respiratory diseases associated with the inhalation of very small particulate matter and other harmful substances during deployment.